In a study performed with a murine model of hepatocellular carcinoma, treatment with a CSF1R inhibitor resulted in increased CD8 infiltration accompanied by a reduction in MDSCs, a profile similar to what we observed in our study with the MC38 CSF1 knockout model [47]. Here, CSF1R is linked to hepatocellular carcinoma.